Caffeic acid protects tissue antioxidants and DNA content in methamphetamine induced tissue toxicity in Sprague Dawley rats

Toxicology Mechanisms and Methods

Volumn 23, Issue 2, 2013, Pages 134-143

  Koriem, Khaled M M ^a,b   Abdelhamid, Abdelhamid Z ^b   Younes, Hady F ^c  

^a ADVANCED MEDICAL AND DENTAL INSTITUTE   (Malaysia)

^b NATIONAL RESEARCH CENTRE   (Egypt)

^c Ein Helwan   (Egypt)

Author keywords

Antioxidant; Caffeic acid; DNA; Methamphetamine; Oxidative stress; Rats

Indexed keywords

CAFFEIC ACID; CARBONYL DERIVATIVE; CATALASE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; MALONALDEHYDE; METHAMPHETAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; BRAIN TOXICITY; CONTROLLED STUDY; DNA CONTENT; DNA DAMAGE; HISTOPATHOLOGY; LIVER TOXICITY; MALE; NEPHROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; SPRAGUE DAWLEY RAT;

ANIMALS; ANTIOXIDANTS; BRAIN; CAFFEIC ACIDS; CENTRAL NERVOUS SYSTEM STIMULANTS; DNA DAMAGE; INJECTIONS, INTRAPERITONEAL; KIDNEY; LIVER; MALE; METHAMPHETAMINE; OXIDATIVE STRESS; OXIDOREDUCTASES; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84873801844     PISSN: 15376516     EISSN: 15376524     Source Type: Journal    
DOI: 10.3109/15376516.2012.730561     Document Type: Article

References (63)

1. Abdallah FB, Fetoui H, Fakhfakh F, Keskes L. 2012. Caffeic acid and quercetin protect erythrocytes against the oxidative stress and the genotoxic effects of lambda-cyhalothrin in vitro. Hum Exp Toxicol 31: 92-100.
2. Achat-Mendes C, Anderson KL, Itzhak Y. 2007. Impairment in consolidation of learned place preference following dopaminergic neurotoxicity in mice is ameliorated by N-acetylcysteine but not D1 and D2 dopamine receptor agonists. Neuropsychopharmacology 32: 531-541.
3. Akg O, Gen S, Gezer S, Kayatekin BM, Uysal N, Semin I, Gure A. 2001. Methamphetamine causes depletion of glutathione and an increase in oxidized glutathione in the rat striatum and prefrontal cortex. Neurotox Res 3: 277-280.
4. Akg O, Gen S, Kayatekin BM, Pektin C, Uysal N, Dayi A, Semin I, Ge A. 2000. The effects of single dose of methamphetamine on lipid peroxidation levels in the rat striatum and prefrontal cortex. Eur Neuropsychopharmacol 10: 415-418.
5. Aebi H. 1984. Catalase in vitro. Meth Enzymol 105: 121-126.
6. Albertson TE, Derlet RW, Van Hoozen BE. 1999. Methamphetamine and the expanding complications of amphetamines. West J Med 170: 214-219.
7. Bassil D, Makris DP, Kefalas P. 2005. Oxidation of caffeic acid in the presence of L-cysteine: isolation of 2-S-cysteinylcaffeic acid and evaluation of its antioxidant properties. Food Res Int 38: 395-402.
8. Burrows KB, Yamamoto BK. 2003. Methamphetamine neurotoxicity: roles for glutamate, oxidative processes and metabolic stress. In: Herman BH, ed. Glutamate and Addiction. New Jersey: Humana Press Inc. 211-227.
9. Bokuroglu ME, Gn I, Oktay M, Krevioglu OI. 2001. In vitro antioxidant properties of dantrolene sodium. Pharmacol Res 44: 491-494.
10. Cadet JL. 2003. Roles of glutamate, nitric oxide, oxidative stress, and apoptosis in the neurotoxicity of methamphetamine. In: Herman BH, ed. Glutamate and Addiction. New Jersey: Humana Press Inc. 201-210.
11. Danque PO, Chen HB, Patil J, Jagirdar J, Orsatti G, Paronetto F. 1993. Image analysis versus flow cytometry for DNA ploidy quantitation of solid tumors: a comparison of six methods of sample preparation. Mod Pathol 6: 270-275.
12. Cartron E, Carbonneau MA, Fouret G, Descomps B, Ler CL. 2001. Specific antioxidant activity of caffeoyl derivatives and other natural phenolic compounds: LDL protection against oxidation and decrease in the proinflammatory lysophosphatidylcholine production. J Nat Prod 64: 480-486.
13. Carvalho F, Remi F, Soares ME, Catarino R, Queiroz G, Bastos ML. 1997. d-Amphetamine-induced hepatotoxicity: possible contribution of catecholamines and hyperthermia to the effect studied in isolated rat hepatocytes. Arch Toxicol 71: 429-436.
14. Darke S, Kaye S, McKetin R, Duflou J. 2008. Major physical and psychological harms of methamphetamine use. Drug Alcohol Rev 27: 253-262.
15. DASIS Report. 2004. Office of Applied Studies. Primary Methamphetamine/Amphetamine Treatment Admissions. 1992-2002.
16. DHHS Publication. 2003. No. SMA 03-3780, DAWN Series D-24. Office of Applied Studies. Emergency Department Trends from Drug Abuse Warning Network, Final Estimates 1995-2002. Rockville, MD: Substance Abuse and Mental Health Services Administration.
17. Duh PD, Tu YY, Yen GC. 1999. Antioxidant activity of water extract of harng jyur (Chrysanthemum morifolium Ramat). Lebens Wiss Technol 32: 269-277.
18. Ellman GL. 1959. Tissue sulfhydryl groups. Arch Biochem Biophys 82: 70-77.
19. Foley S, Navaratnam S, McGarvey DJ, Land EJ, Truscott TG, Rice-Evans CA. 1999. Singlet oxygen quenching and the redox properties of hydroxycinnamic acids. Free Radic Biol Med 26: 1202-1208.
20. Fukumoto LR, Mazza G. 2000. Assessing antioxidant and prooxidant activities of phenolic compounds. J Agric Food Chem 48: 3597-3604.
21. Glasner-Edwards S, Marinelli-Casey P, Hillhouse M, Ang A, Mooney LJ, Rawson R; Methamphetamine Treatment Project Corporate Authors. 2009. Depression among methamphetamine users: association with outcomes from the Methamphetamine Treatment Project at 3-year follow-up. J Nerv Ment Dis 197: 225-231.
22. Fleckenstein AE, Gibb JW, Hanson GR. 2000. Differential effects of stimulants on monoaminergic transporters: pharmacological consequences and implications for neurotoxicity. Eur J Pharmacol 406: 1-13.
23. Giros B, Jaber M, Jones SR, Wightman RM, Caron MG. 1996. Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature 379: 606-612.
24. Gluck MR, Moy LY, Jayatilleke E, Hogan KA, Manzino L, Sonsalla PK. 2001. Parallel increases in lipid and protein oxidative markers in several mouse brain regions after methamphetamine treatment. J Neurochem 79: 152-160.
25. Gong P, Chen F, Liu X, Gong X, Wang J, Ma Y. 2012. Protective effect of caffeic acid phenethyl ester against cadmium-induced renal damage in mice. J Toxicol Sci 37: 415-425.
26. Gonzales R, Mooney L, Rawson RA. 2010. The methamphetamine problem in the United States. Annu Rev Public Health 31: 385-398.
27. Gn I. 2006. Antioxidant activity of caffeic acid (3,4-dihydroxycinnamic acid). Toxicology 217: 213-220.
28. Homer BD, Solomon TM, Moeller RW, Mascia A, DeRaleau L, Halkitis PN. 2008. Methamphetamine abuse and impairment of social functioning: a review of the underlying neurophysiological causes and behavioral implications. Psychol Bull 134: 301-310.
29. Jaganathan SK. 2012. Growth inhibition by caffeic acid, one of the phenolic constituents of honey, in HCT 15 colon cancer cells. The Sci World J 2012: 1-8.
30. Jayanthi S, Ladenheim B, Cadet JL. 1998. Methamphetamine-induced changes in antioxidant enzymes and lipid peroxidation in copper/zinc-superoxide dismutase transgenic mice. Ann NY Acad Sci 844: 92-102.
31. Jones AL, Simpson KJ. 1999. Review article: mechanisms and management of hepatotoxicity in ecstasy (MDMA) and amphetamine intoxications. Aliment Pharmacol Ther 13: 129-133.
32. Kamijo Y, Soma K, Nishida M, Namera A, Ohwada T. 2002. Acute liver failure following intravenous methamphetamine. Vet Hum Toxicol 44: 216-217.
33. Kerry N, Rice-Evans C. 1998. Peroxynitrite oxidises catechols to o-quinones. FEBS Lett 437: 167-171.
34. Kikuzaki H, Hisamoto M, Hirose K, Akiyama K, Taniguchi H. 2002. Antioxidant properties of ferulic acid and its related compounds. J Agric Food Chem 50: 2161-2168.
35. Kim HC, Jhoo WK, Choi DY, Im DH, Shin EJ, Suh JH, Floyd RA, Bing G. 1999. Protection of methamphetamine nigrostriatal toxicity by dietary selenium. Brain Res 851: 76-86.
36. Kitsati N, Fokas D, Ouzouni MD, Mantzaris MD, Barbouti A, Galaris D. 2012. Lipophilic caffeic acid derivatives protect cells against H2O2-induced DNA damage by chelating intracellular labile iron. J Agric Food Chem [Epub ahead of print].
37. Lan KC, Lin YF, Yu FC, Lin CS, Chu P. 1998. Clinical manifestations and prognostic features of acute methamphetamine intoxication. J Formos Med Assoc 97: 528-533.
38. Laranjinha J, Vieira O, Madeira V, Almeida L. 1995. Two related phenolic antioxidants with opposite effects on vitamin E content in low density lipoproteins oxidized by ferrylmyoglobin: consumption vs regeneration. Arch Biochem Biophys 323: 373-381.
39. Levine RL, Garland D, Oliver CN, Amici A, Climent I, Lenz AG, Ahn BW, Shaltiel S, Stadtman ER. 1990. Determination of carbonyl content in oxidatively modified proteins. Meth Enzymol 186: 464-478.
40. Melo P, Rodrigues LG, Pinazo-Dur MD, Tavares MA. 2005. Methamphetamine and lipid peroxidation in the rat retina. Birth Defects Res Part A Clin Mol Teratol 73: 455-460.
41. Melo P, Pinazo-Dur MD, Salgado-Borges J, Tavares MA. 2008. Correlation of axon size and myelin occupancy in rats prenatally exposed to methamphetamine. Brain Res 1222: 61-68.
42. Meredith CW, Jaffe C, Ang-Lee K, Saxon AJ. 2005. Implications of chronic methamphetamine use: a literature review. Harv Rev Psychiatry 13: 141-154.
43. Meyer AS, Donovan JL, Pearson DA,Waterhouse AL, Frankel EN. 1998. Fruit hydroxycinnamic acids inhibit low density lipoprotein oxidation in vitro. J Agric Food Chem 46: 1783-1787.
44. Mooney LJ, Glasner-Edwards S, Rawson RA, Ling W. 2009. Medical effects of methamphetamine use. In: Roll JM, Rawson RA, Ling W, Shoptaw S, eds. Methamphetamine Addiction: From Basic Science to Treatment. New York: The Guilford Press, 117-142.
45. NSDUH Report.2007. Methamphetamine Use. Rockville, MD: Substance Abuse and Mental Health Services Administration. Office of Applied Studies. Office of Applied Studies.
46. Ohkawa H, Ohishi N, Yagi K. 1979. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95: 351-358.
47. Paglia DE, Valentine WN. 1967. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 70: 158-169.
48. Richards JR, Johnson EB, Stark RW, Derlet RW. 1999. Methamphetamine abuse and rhabdomyolysis in the ED: a 5-year study. Am J Emerg Med 17: 681-685.
49. Sbrana I, Di Sibio A, Lomi A, Scarcelli V. 1993. C-mitosis and numerical chromosome aberration analyses in human lymphocytes: 10 known or suspected spindle poisons. Mutat Res 287: 57-70.
50. Scott JC, Woods SP, Matt GE, Meyer RA, Heaton RK, Atkinson JH, Grant I. 2007. Neurocognitive effects of methamphetamine: a critical review and meta-analysis. Neuropsychol Rev 17: 275-297.
51. Shima N, Miyawaki I, Bando K, Horie H, Zaitsu K, Katagi M, Bamba T, Tsuchihashi H, Fukusaki E. 2011. Influences of methamphetamineinduced acute intoxication on urinary and plasma metabolic profiles in the rat. Toxicology 287: 29-37.
52. Shrem MT, Halkitis PN. 2008. Methamphetamine abuse in the United States: contextual, psychological and sociological considerations. J Health Psychol 13: 669-679.
53. Sprong RC, Winkelhuyzen-Janssen AM, Aarsman CJ, van Oirschot JF, van der Bruggen T, van Asbeck BS. 1998. Low-dose N-acetylcysteine protects rats against endotoxin-mediated oxidative stress, but high-dose increases mortality. Am J Respir Crit Care Med 157: 1283-1293.
54. Sroka Z, Cisowski W. 2003. Hydrogen peroxide scavenging, antioxidant and anti-radical activity of some phenolic acids. Food Chem Toxicol 41: 753-758.
55. Stumm G, Schlegel J, Scher T, Wz C, Mennel HD, Krieg JC, Vedder H. 1999. Amphetamines induce apoptosis and regulation of bcl-x splice variants in neocortical neurons. FASEB J 13: 1065-1072.
56. Tavassoly O, Lee JS. 2012. Methamphetamine binds to α-synuclein and causes a conformational change which can be detected by nanopore analysis. FEBS Lett [Epub ahead of print].
57. Tokunaga I, Kubo S, Ishigami A, Gotohda T, Kitamura O. 2006. Changes in renal function and oxidative damage in methamphetaminetreated rat. Leg Med (Tokyo) 8: 16-21.
58. Treatment Episode Data Set (TEDS) Highlights-2004. 2006. National Admissions to Substance Abuse Treatment Services. Rockville, MD: Substance Abuse and Mental Health Services Administration.
59. Weng YC, Chuang ST, Lin YC, Chuang CF, Chi TC, Chiu HL, Kuo YH, Su MJ. 2012. Caffeic Acid Phenylethyl Amide Protects against the Metabolic Consequences in Diabetes Mellitus Induced by Diet and Streptozocin. Evid Based Complement Alternat Med 2012: 984780.
60. Yamamoto BK, Zhu W. 1998. The effects of methamphetamine on the production of free radicals and oxidative stress. J Pharmacol Exp Ther 287: 107-114.
61. Yu Q, Larson DF, Watson RR. 2003. Heart disease, methamphetamine and AIDS. Life Sci 73: 129-140.
62. Zhu QY, Hackman RM, Ensunsa JL, Holt RR, Keen CL. 2002. Antioxidative activities of oolong tea. J Agric Food Chem 50: 6929-6934.
63. Zweben JE, Cohen JB, Christian D, Galloway GP, Salinardi M, Parent D, Iguchi M; Methamphetamine Treatment Project. 2004. Psychiatric symptoms in methamphetamine users. Am J Addict 13: 181-190.